The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells

Virology. 2007 Mar 15;359(2):243-52. doi: 10.1016/j.virol.2006.09.026. Epub 2006 Oct 23.

Abstract

The viral infectivity factor gene (vif) of HIV-1 increases the infectivity of viral particles by inactivation of cellular anti-viral factors, and supports productive viral replication in primary human CD4 T cells and in certain non-permissive T cell lines. Here, we demonstrate that Vif also contributes to the arrest of HIV-1 infected cells in the G(2) phase of the cell cycle. Viruses deleted in Vif or Vpr induce less cell cycle arrest than wild-type virus, while cells infected with HIV-1 deleted in both Vif and Vpr have a cell cycle profile equivalent to that of uninfected cells. Furthermore, expression of Vif alone induces accumulation of cells in the G(2) phase of the cell cycle. These data demonstrate a novel role for Vif in cell cycle regulation and suggest that Vif and Vpr independently drive G(2) arrest in HIV-1 infected cells. Our results may have implications for the actions and interactions of key HIV-1 accessory proteins in AIDS pathogenesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Cycle*
  • Cells, Cultured
  • Gene Expression Regulation, Viral
  • Gene Products, vif / genetics
  • Gene Products, vif / metabolism*
  • Gene Products, vpr / genetics
  • Gene Products, vpr / metabolism
  • HIV-1 / genetics
  • HIV-1 / physiology*
  • Humans
  • Jurkat Cells
  • Mutation
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / physiology
  • T-Lymphocytes / virology*
  • vif Gene Products, Human Immunodeficiency Virus
  • vpr Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, vif
  • Gene Products, vpr
  • vif Gene Products, Human Immunodeficiency Virus
  • vpr Gene Products, Human Immunodeficiency Virus